Sandra Alonso‐Gil - Concepedia

Author

Sandra Alonso‐Gil

Biomedical Research Networking Center on Neurodegenerative Diseases

Also Known As

Petra Terešak, S Alonso‐Gil, S. Alonso-Gil, Sandra Alonso-Gil, Sandra Alonso‐Gil

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Biomedical Research Networking Center on Neurodegenerative Diseases Universidad Autónoma de Madrid Instituto de Investigaciones Biomédicas Sols-Morreale Instituto de Química Médica Universidad Complutense de Madrid

About

Sandra Alonso‐Gil is an author at Biomedical Research Networking Center on Neurodegenerative Diseases specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	661
2	Social Sciences	6	6	376
3	Natural Sciences	3	3	228
4	Biochemistry	3	3	92
5	Engineering	1	1	18

Sandra Alonso‐Gil

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro José Á. Morales-García, Mario de la Fuente Revenga, Sandra Alonso‐Gil, Scientific Reports BiologyPsychoactive DrugDevelopmental BiologyBotanyNeurophysiology	2017	166
Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo José Á. Morales-García, Rosario Luna‐Medina, Sandra Alonso‐Gil, ACS Chemical Neuroscience Brain DevelopmentSmall Molecule Np03112Cellular NeurobiologySocial SciencesNeuroregeneration	2012	154
N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo José Á. Morales-García, Javier Calleja‐Conde, Jose Antonio López‐Moreno, Translational Psychiatry	2020	132
Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease José Á. Morales-García, Miriam Redondo, Sandra Alonso‐Gil, PLoS ONE	2011	101
5-Imino-1,2,4-Thiadiazoles: First Small Molecules As Substrate Competitive Inhibitors of Glycogen Synthase Kinase 3 Valle Palomo, Daniel I. Pérez, Concepción Pérez, Journal of Medicinal Chemistry	2012	88
New Melatonin–<i>N</i>,<i>N</i>-Dibenzyl(<i>N</i>-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease Beatriz López-Iglesias, Concepción Pérez, José Á. Morales-García, Journal of Medicinal Chemistry	2014	86
Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease. José Á. Morales-García, Cristina Susín, Sandra Alonso‐Gil, ACS Chemical Neuroscience Nigrostriatal Dopaminergic PathwayNeurochemical BiomarkersPharmacotherapySocial SciencesMolecular Pharmacology	2012	77
Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy Jesús Alarcón-Gil, Ana Sierra‐Magro, José Á. Morales-García, Cells	2022	75
Effect of Phosphodiesterase 7 (PDE7) Inhibitors in Experimental Autoimmune Encephalomyelitis Mice. Discovery of a New Chemically Diverse Family of Compounds Miriam Redondo, José Brea, Daniel I. Pérez, Journal of Medicinal Chemistry Phosphodiesterase 7ImmunologyNeurochemical BiomarkersImmune SystemPharmaceutical Chemistry	2012	57
Phosphodiesterase 7 Inhibition Induces Dopaminergic Neurogenesis in Hemiparkinsonian Rats José Á. Morales-García, Sandra Alonso‐Gil, Carmen Gil, Stem Cells Translational Medicine	2015	44

Page 1